Intestinal dysbiosis and potential consequences of microbiome-altering antibiotic use in the pathogenesis of human rheumatic disease
J Rheumatol
.
2015 Mar;42(3):355-7.
doi: 10.3899/jrheum.150036.
Author
Jose U Scher
1
Affiliation
1
New York University School of Medicine; and Hospital for Joint Diseases, Department of Medicine, 301 E. 17th St., New York 10003, New York, USA; E-mail: jose.scher@nyumc.org.
PMID:
25729039
DOI:
10.3899/jrheum.150036
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anti-Bacterial Agents / therapeutic use*
Arthritis, Juvenile / etiology*
Bacterial Infections / drug therapy*
Female
Humans
Male
Substances
Anti-Bacterial Agents
Grants and funding
K23 AR064318/AR/NIAMS NIH HHS/United States